Advisory Services Network, LLC Jounce Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 24, 2021	SELL	$6.73 - $13.87 $545 - $1,123	-81 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.58 - $10.95 $370 - $886	81 New	81 $1,000
Q2 2020 Aug 10, 2020	SELL	$4.17 - $7.58 $337 - $613	-81 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.91 - $8.7 $46 - $139	16 Added 24.62%	81 $0
Q4 2019 Feb 04, 2020	BUY	$2.81 - $9.21 $182 - $598	65 New	65 $1,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.